Joke van der Linden

Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial

Emanuele Bosi, Pratik Choudhary, Harold W. de Valk et al. · The Lancet Diabetes & Endocrinology · 2019 · 121 citations

Type 1, Hypoglycaemia-prone Adults, Diabetes Management +7

Graft surveillance: Venous pressure, access flow, or the combination?

Johannes H. M. Smits, Joke van der Linden, E. Chris Hagen et al. · Kidney International · 2001 · 112 citations · Full text

Venous Disease, Vascular Surgery, Graft Surveillance +3

Plant-derived anti-Lewis Y mAb exhibits biological activities for efficient immunotherapy against human cancer cells

Robert Brodzik, Magdalena J. Glogowska, Katarzyna Bandurska et al. · Proceedings of the National Academy of Sciences · 2006 · 89 citations · Full text

Immunology, Biological Therapy, Biological Activities +16

Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodies.

Gerwin Huls, Ingmar Heijnen, Emanuela M. Cuomo et al. · PubMed · 1999 · 82 citations

Cancer Immunosurveillance, Iga1 Monoclonal Antibodies, Fc Receptor +14

Short- and Long-Term Functional Effects of Percutaneous Transluminal Angioplasty in Hemodialysis Vascular Access

Joke van der Linden, Johannes H. M. Smits, Jan H. Assink et al. · Journal of the American Society of Nephrology · 2002 · 81 citations · Full text

Endovascular Technique, Dialysis Therapy, Surgery +22